Shenzhen Salubris Pharmaceuticals Co Ltd (002294.SZ) stock: key figures, P/E, revenue and dividend
Health Care · Pharmaceuticals · China · ISIN CNE100000FW8
Shenzhen Salubris Pharmaceuticals Co Ltd financials
| Fiscal year | 2023 | 2024 |
|---|---|---|
| Revenue | 3.37 bn CNY | 4.01 bn CNY |
| Gross profit | 2.30 bn CNY | 2.87 bn CNY |
| Operating income | 655.98 m CNY | 646.31 m CNY |
| EBIT | 565.82 m CNY | 683.93 m CNY |
| Net income | 580.07 m CNY | 601.57 m CNY |
| Diluted EPS – continuing operations | 0.52 CNY | 0.54 CNY |
Full history since 2006, charts and your own formulas
This page shows the last two fiscal years. After free sign-up you get the full income statement, balance sheet and cash flow, price and dividend charts, your own formula metrics and a stock screener covering more than 8,000 companies.
About Shenzhen Salubris Pharmaceuticals Co Ltd
Shenzhen Salubris Pharmaceuticals Co., Ltd. engages in the research, development, production, and sale of pharmaceuticals and medical devices in China. The company is involved in the production and supply of pharmaceutical products in the fields of chronic diseases, including cardiovascular and cerebrovascular diseases, diabetes, oncology, osteoporosis, anti-infective diseases, and chronic kidney diseases. It also engages in the research and development, production, and sale of high-end interventional medical devices, such as cardiovascular and cerebrovascular, peripheral vascular, structural heart disease, electrophysiology, and cardiac rhythm management. The company was incorporated in 1998 and is headquartered in Shenzhen, China. Shenzhen Salubris Pharmaceuticals Co., Ltd. operates as a subsidiary of Salubris Pharmaceuticals Co., Ltd.
More stocks
- AAC Technologies Holdings Inc (2018.HK)
- CNO Financial Group, Inc. (CNO)
- BOCHGR (BOCHGR.AT)
- Nestle (Malaysia) Bhd (4707.KL)
- St Galler Kantonalbank AG (SGKN.SW)
- Axos Financial, Inc. (AX)
- Tokyo Electric Power Company Holdings Inc (9501.T)
- CHOICE HOTELS INTERNATIONAL INC /DE (CHH)
- Enagas SA (ENG.MC)
- Dyno Nobel Ltd (DNL.AX)
- Skylark Holdings Co Ltd (3197.T)
- Burberry Group PLC (BRBY.L)
Not investment advice. All data without warranty, price as of 22.10.2026. Details in the risk notice.